Selected research
Industry Research
Pefloxacin Mesylate Industry Research Report 2026
Market perspective
The global Pefloxacin Mesylate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pefloxacin Mesylate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pefloxacin Mesylate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pefloxacin Mesylate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pefloxacin Mesylate include AdvaCare Pharma, Beijing Shuanglu Pharmaceutical Co., Ltd., Beijing Sihuan Pharmaceutical Co., Ltd., China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd., CommScope Pharmaceutical Co., Ltd., Ruiyang Pharmaceutical Co., Ltd., Shandong Lukang Pharmaceutical Group Saite Co., Ltd. and Yichang Renfu Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pefloxacin Mesylate market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pefloxacin Mesylate Market by Company
AdvaCare Pharma
Beijing Shuanglu Pharmaceutical Co., Ltd.
Beijing Sihuan Pharmaceutical Co., Ltd.
China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd.
CommScope Pharmaceutical Co., Ltd.
Ruiyang Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Group Saite Co., Ltd.
Yichang Renfu Pharmaceutical Co., Ltd.
Pefloxacin Mesylate Segment by Type
Capsule
Tablet
Injection
Pefloxacin Mesylate Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
Pefloxacin Mesylate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pefloxacin Mesylate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pefloxacin Mesylate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pefloxacin Mesylate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pefloxacin Mesylate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pefloxacin Mesylate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pefloxacin Mesylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule
- Tablet
- Injection
Applications
- Hospital Pharmacy
- Retail Pharmacy
- Others
Companies covered
- AdvaCare Pharma
- Beijing Shuanglu Pharmaceutical Co., Ltd.
- Beijing Sihuan Pharmaceutical Co., Ltd.
- China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd.
- CommScope Pharmaceutical Co., Ltd.
- Ruiyang Pharmaceutical Co., Ltd.
- Shandong Lukang Pharmaceutical Group Saite Co., Ltd.
- Yichang Renfu Pharmaceutical Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pefloxacin Mesylate Market Size (2021-2032)
- 2.2.2 Global Pefloxacin Mesylate Sales (2021-2032)
- 2.2.3 Global Pefloxacin Mesylate Market Average Price (2021-2032)
- 2.3 Pefloxacin Mesylate by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Capsule
- 2.3.3 Tablet
- 2.3.4 Injection
- 2.4 Pefloxacin Mesylate by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacy
- 2.4.3 Retail Pharmacy
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pefloxacin Mesylate Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pefloxacin Mesylate Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Pefloxacin Mesylate Revenue of Manufacturers (2021-2026)
- 3.4 Global Pefloxacin Mesylate Average Price by Manufacturers (2021-2026)
- 3.5 Global Pefloxacin Mesylate Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pefloxacin Mesylate, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pefloxacin Mesylate, Product Type & Application
- 3.8 Global Manufacturers of Pefloxacin Mesylate, Established Date
- 3.9 Global Pefloxacin Mesylate Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 AdvaCare Pharma
- 4.1.1 AdvaCare Pharma Company Information
- 4.1.2 AdvaCare Pharma Business Overview
- 4.1.3 AdvaCare Pharma Pefloxacin Mesylate Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 AdvaCare Pharma Pefloxacin Mesylate Product Portfolio
- 4.1.5 AdvaCare Pharma Recent Developments
- 4.2 Beijing Shuanglu Pharmaceutical Co., Ltd.
- 4.2.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
- 4.2.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Business Overview
- 4.2.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio
- 4.2.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments
- 4.3 Beijing Sihuan Pharmaceutical Co., Ltd.
- 4.3.1 Beijing Sihuan Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Beijing Sihuan Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio
- 4.3.5 Beijing Sihuan Pharmaceutical Co., Ltd. Recent Developments
- 4.4 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd.
- 4.4.1 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Company Information
- 4.4.2 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Business Overview
- 4.4.3 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Product Portfolio
- 4.4.5 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Recent Developments
- 4.5 CommScope Pharmaceutical Co., Ltd.
- 4.5.1 CommScope Pharmaceutical Co., Ltd. Company Information
- 4.5.2 CommScope Pharmaceutical Co., Ltd. Business Overview
- 4.5.3 CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio
- 4.5.5 CommScope Pharmaceutical Co., Ltd. Recent Developments
- 4.6 Ruiyang Pharmaceutical Co., Ltd.
- 4.6.1 Ruiyang Pharmaceutical Co., Ltd. Company Information
- 4.6.2 Ruiyang Pharmaceutical Co., Ltd. Business Overview
- 4.6.3 Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio
- 4.6.5 Ruiyang Pharmaceutical Co., Ltd. Recent Developments
- 4.7 Shandong Lukang Pharmaceutical Group Saite Co., Ltd.
- 4.7.1 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Company Information
- 4.7.2 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Business Overview
- 4.7.3 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Product Portfolio
- 4.7.5 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Recent Developments
- 4.8 Yichang Renfu Pharmaceutical Co., Ltd.
- 4.8.1 Yichang Renfu Pharmaceutical Co., Ltd. Company Information
- 4.8.2 Yichang Renfu Pharmaceutical Co., Ltd. Business Overview
- 4.8.3 Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio
- 4.8.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
5 Global Pefloxacin Mesylate Market Scenario by Region
- 5.1 Global Pefloxacin Mesylate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pefloxacin Mesylate Sales by Region: 2021-2032
- 5.2.1 Global Pefloxacin Mesylate Sales by Region: 2021-2026
- 5.2.2 Global Pefloxacin Mesylate Sales by Region: 2027-2032
- 5.3 Global Pefloxacin Mesylate Revenue by Region: 2021-2032
- 5.3.1 Global Pefloxacin Mesylate Revenue by Region: 2021-2026
- 5.3.2 Global Pefloxacin Mesylate Revenue by Region: 2027-2032
- 5.4 North America Pefloxacin Mesylate Market Facts & Figures by Country
- 5.4.1 North America Pefloxacin Mesylate Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pefloxacin Mesylate Sales by Country (2021-2032)
- 5.4.3 North America Pefloxacin Mesylate Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Pefloxacin Mesylate Market Facts & Figures by Country
- 5.5.1 Europe Pefloxacin Mesylate Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pefloxacin Mesylate Sales by Country (2021-2032)
- 5.5.3 Europe Pefloxacin Mesylate Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Pefloxacin Mesylate Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pefloxacin Mesylate Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pefloxacin Mesylate Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pefloxacin Mesylate Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pefloxacin Mesylate Market Facts & Figures by Country
- 5.7.1 South America Pefloxacin Mesylate Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pefloxacin Mesylate Sales by Country (2021-2032)
- 5.7.3 South America Pefloxacin Mesylate Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Pefloxacin Mesylate Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pefloxacin Mesylate Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pefloxacin Mesylate Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pefloxacin Mesylate Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Pefloxacin Mesylate Sales by Type (2021-2032)
- 6.1.1 Global Pefloxacin Mesylate Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Pefloxacin Mesylate Sales Market Share by Type (2021-2032)
- 6.2 Global Pefloxacin Mesylate Revenue by Type (2021-2032)
- 6.2.1 Global Pefloxacin Mesylate Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pefloxacin Mesylate Revenue Market Share by Type (2021-2032)
- 6.3 Global Pefloxacin Mesylate Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pefloxacin Mesylate Sales by Application (2021-2032)
- 7.1.1 Global Pefloxacin Mesylate Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Pefloxacin Mesylate Sales Market Share by Application (2021-2032)
- 7.2 Global Pefloxacin Mesylate Revenue by Application (2021-2032)
- 7.2.1 Global Pefloxacin Mesylate Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pefloxacin Mesylate Revenue Market Share by Application (2021-2032)
- 7.3 Global Pefloxacin Mesylate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pefloxacin Mesylate Value Chain Analysis
- 8.1.1 Pefloxacin Mesylate Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pefloxacin Mesylate Production Mode & Process
- 8.2 Pefloxacin Mesylate Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pefloxacin Mesylate Distributors
- 8.2.3 Pefloxacin Mesylate Customers
9 Global Pefloxacin Mesylate Analyzing Market Dynamics
- 9.1 Pefloxacin Mesylate Industry Trends
- 9.2 Pefloxacin Mesylate Industry Drivers
- 9.3 Pefloxacin Mesylate Industry Opportunities and Challenges
- 9.4 Pefloxacin Mesylate Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst